Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Robert L. Tansik"'
Autor:
Lee F. Kuyper, Karl D. Hardman, Robert L. Tansik, Jean S. Hong, David Stewart, Marc Whitlow, Joseph H. Chan, Andrew J. Howard, David P. Baccanari
Publikováno v:
Journal of Medicinal Chemistry. 44:2928-2932
X-ray crystallographic analysis of 5-(4'-substituted phenyl)sulfanyl-2,4-diaminoquinazoline inhibitors in ternary complex with Candida albicans dihydrofolate reductase (DHFR) and NADPH revealed two distinct modes of binding. The two compounds with sm
Autor:
Youcef M. Rustum, Stephen T. Davis, Shousong Cao, Thomas Spector, Robert L. Tansik, David P. Baccanari, Melanie T Paff
Publikováno v:
Investigational New Drugs. 18:365-371
Eniluracil (5-ethynyluracil, GW 776, 776C85) is being developed as a novel modulator of 5-fluorouracil (5-FU) for the treatment of cancer. Eniluracil is an effective mechanism-based inactivator of dihydropyrimidine dehydrogenase (DPD), the first enzy
Autor:
Youcef M. Rustum, Robert L Tansik, Thomas Spector, Stephen T. Davis, David P. Baccanari, Shousong Cao, David J.T. Porter
Publikováno v:
Biochemical Pharmacology. 59:953-960
We have shown previously that (R)-5-fluoro-5,6-dihydrouracil (FUraH(2)) attenuates the antitumor activity of 5-fluorouracil (FUra) in rats bearing advanced colorectal carcinoma. Presently, we found that alpha-fluoro-beta-alanine (FBAL), the predomina
Autor:
Lee F. Kuyper, Christine M. Boytos, Michael L. Jones, David P. Baccanari, Sharon K. Rudolph, Robert L. Tansik
Publikováno v:
Journal of Heterocyclic Chemistry. 36:145-148
Novel 2,4-diamino-6-methyl-5-ethynylpyrimidines were prepared via palladium catalyzed coupling of 2,4-diamino-5-iodo-6-methyl-pyrimidine with terminal acetylenes. The compounds were inhibitors of dihydrofolate reductase and showed in vitro activity a
Autor:
Mary E. Fling, Marc Whitlow, Karl D. Hardman, Lee F. Kuyper, David P. Baccanari, David H. Stewart, Robert L. Tansik, Andrew Howard
Publikováno v:
Journal of Biological Chemistry. 272:30289-30298
The recent rise in systemic fungal infections has created a need for the development of new antifungal agents. As part of an effort to provide therapeutically effective inhibitors of fungal dihydrofolate reductase (DHFR), we have cloned, expressed, p
Autor:
Steven E. Cwirla, Palaniappan Balasubramanian, Ronald W. Barrett, Nicholas C. Wrighton, Peter J. Schatz, Wagstrom Christopher R, Duffin David J, David P. Baccanari, Robert L. Tansik, Sara C. Singer, Ann M. Davis, Chris M. Boytos, Christian M. Gates, William J. Dower, Larry C. Mattheakis
Publikováno v:
Science. 276:1696-1699
Two families of small peptides that bind to the human thrombopoietin receptor and compete with the binding of the natural ligand thrombopoietin (TPO) were identified from recombinant peptide libraries. The sequences of these peptides were not found i
Autor:
Sharon K. Rudolph, Lee F. Kuyper, Christine M. Boytos, Joseph H. Chan, David P. Baccanari, Jean S. Hong, Robert L. Tansik, Andrew D. Brown, Michael L. Jones
Publikováno v:
Journal of Heterocyclic Chemistry. 34:145-151
A series of novel 1,3-diamino-7,8,9,10-tetrahydropyrido[3,2-f]quinazolines were synthesized starting from 6-amino-5-cyanoquinoline (4). These compounds inhibited Candida albicans dihydrofolate reductase with Ki values of ≤0.60 aM. One analogue exhi
Autor:
Lee F. Kuyper, Robert L. Tansik, H. S. Friedman, Victoria B. Knick, Michael L. Jones, J. C. W. Comley, David P. Baccanari, H. R. Wilson, Christine M. Boytos, J. N. Stables, Robert N. Hunter, Sharon K. Rudolph, S. S. Joyner, J. M. Caddell
Publikováno v:
Journal of Medicinal Chemistry. 39:892-903
A series of 7,8-dialkylpyrrolo[3,2-f]quinazolines were prepared as inhibitors of dihydrofolate reductase (DHFR). On the basis of an apparent inverse relationship between compound size and antifungal activity, the compounds were designed to be relativ
Autor:
Robert L. Tansik, Sharon K. Rudolph, Christine M. Boytos, Virgil L. Styles, Joseph H. Chan, G. Erik Jagdmann
Publikováno v:
Journal of Heterocyclic Chemistry. 32:1461-1465
Several 5-(4-substituted benzyl)-2,4-diaminoquinazolines were prepared as potentially selective inhibitors of Candida albicans dihydrofolate reductase. These compounds were synthesized by a novel route, which included as a key step the displacement o
Autor:
Robert L. Tansik, Joseph H. Chan, David P. Baccanari, Sharon K. Rudolph, Lee F. Kuyper, Jean S. Hong, Christine M. Boytos, S. S. Joyner
Publikováno v:
ChemInform. 26
The recent increase in fungal infections, especially among AIDS patients, has resulted in the need for more effective antifungal agents. In our search for such agents, we focused on developing compounds which inhibit fungal dihydrofolate reductase (D